Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Khorsand

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Neurology|August 1, 1996
Multiple cerebral lesions complicating therapy with interleukin-2B I Karp, J C Yang, M Khorsand, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 19, 2012
Control of human spine in repetitive sagittal plane flexion and extension motion using a CPG based ANN approachA Sedighi, N Sadati, B Nasseroleslami, et al.
Investigational New Drugs|January 1, 1997
Phase II trial of oral piritrexim in advanced, previously treated transitional cell cancer of bladderM Khorsand, J Lange, L Feun, et al.
Materials Science & Engineering. C, Materials for Biological Applications|May 22, 2016
Surface modification of electrospun PLGA scaffold with collagen for bioengineered skin substitutesA R Sadeghi, S Nokhasteh, A M Molavi, et al.
Cancer|March 10, 2001
Central venous device-related infection and thrombosis in patients treated with moderate dose continuous-infusion interleukin-2M E Eastman, M Khorsand, D G Maki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999
Distinct clinical and laboratory activity of two recombinant interleukin-2 preparationsJ A Hank, J Surfus, J Gan, et al.
Journal of the Endocrine Society|July 11, 2022
Severe Cholestatic Jaundice (Stauffer Syndrome) as a Rare Paraneoplastic Manifestation in Adrenocortical CarcinomaNatia Murvelashvili, Patricio M Polanco, Sarah M Khorsand, et al.
Cancer|April 13, 2000
A phase Ib/II trial of granulocyte-macrophage-colony stimulating factor and interleukin-2 for renal cell carcinoma patients with pulmonary metastases: a case of fatal central nervous system thrombosisK M Hotton, M Khorsand, J A Hank, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patientsM R Albertini, J A Hank, J H Schiller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Clinical and immunological effects of granulocyte-macrophage colony-stimulating factor coadministered with interleukin 2: a phase IB studyJ H Schiller, J A Hank, M Khorsand, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Neurology|August 1, 1996
Multiple cerebral lesions complicating therapy with interleukin-2B I Karp, J C Yang, M Khorsand, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 19, 2012
Control of human spine in repetitive sagittal plane flexion and extension motion using a CPG based ANN approachA Sedighi, N Sadati, B Nasseroleslami, et al.
Investigational New Drugs|January 1, 1997
Phase II trial of oral piritrexim in advanced, previously treated transitional cell cancer of bladderM Khorsand, J Lange, L Feun, et al.
Materials Science & Engineering. C, Materials for Biological Applications|May 22, 2016
Surface modification of electrospun PLGA scaffold with collagen for bioengineered skin substitutesA R Sadeghi, S Nokhasteh, A M Molavi, et al.
Cancer|March 10, 2001
Central venous device-related infection and thrombosis in patients treated with moderate dose continuous-infusion interleukin-2M E Eastman, M Khorsand, D G Maki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 1999
Distinct clinical and laboratory activity of two recombinant interleukin-2 preparationsJ A Hank, J Surfus, J Gan, et al.
Journal of the Endocrine Society|July 11, 2022
Severe Cholestatic Jaundice (Stauffer Syndrome) as a Rare Paraneoplastic Manifestation in Adrenocortical CarcinomaNatia Murvelashvili, Patricio M Polanco, Sarah M Khorsand, et al.
Cancer|April 13, 2000
A phase Ib/II trial of granulocyte-macrophage-colony stimulating factor and interleukin-2 for renal cell carcinoma patients with pulmonary metastases: a case of fatal central nervous system thrombosisK M Hotton, M Khorsand, J A Hank, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1997
Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patientsM R Albertini, J A Hank, J H Schiller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Clinical and immunological effects of granulocyte-macrophage colony-stimulating factor coadministered with interleukin 2: a phase IB studyJ H Schiller, J A Hank, M Khorsand, et al.
Pageof 1